Selleri C, Sato T, Anderson S, Young N S, Maciejewski J P
Hematology Branch, National Heart, Lung and Blood Institute, Bethesda, Maryland 20892, USA.
J Cell Physiol. 1995 Dec;165(3):538-46. doi: 10.1002/jcp.1041650312.
Increased expression of interferon gamma (IFN-gamma) and tumor necrosis factor alpha (TNF-alpha) in bone marrow failure disorders suggests a possible pathophysiologic role of these cytokines in disease. In this study, we tested the action of TNF-alpha and IFN-gamma on phenotypically and functionally defined stages of hematopoietic development using highly purified progenitor cell populations assayed in standardized culture systems. We hypothesized that the inhibitory effects of IFN-gamma and TNF-alpha might be related to the induction of programmed cell death. In methylcellulose colony assays, IFN-gamma and TNF-alpha inhibited the growth of early hematopoietic cells, including committed CD34+CD38+ progenitor cells and phenotypically less mature CD34+CD38- cells, with 50% decreased colony formation occurring in the range of 750-1,000 U/ml of IFN-gamma and 10-15 ng/ml of TNF-alpha. More potent suppressive effects were observed in cultures supplemented with the combination of both cytokines than in cultures treated with IFN-gamma or TNF-alpha alone. When used at these concentrations, IFN-gamma and TNF-alpha inhibited growth of CD34(+)-enriched long-term culture-initiating cells by 88% and 68%, respectively. IFN-gamma and TNF-alpha triggered apoptosis of total bone marrow and CD34+ cells, recognized by the presence of a characteristic pattern of DNA degradation after low molecular weight DNA extraction, and by detection of apoptotic cells by the in situ terminal deoxynucleotidyl transferase assay. We speculate that chronic exposure of hematopoietic tissue to TNF-alpha and IFN-gamma in vivo may result in broad depletion of the stem and progenitor cell pools. Death of these cells due to apoptosis rather than transient inhibition of proliferation may be responsible for long-lasting hematologic consequences.
骨髓衰竭性疾病中γ干扰素(IFN-γ)和肿瘤坏死因子α(TNF-α)表达增加,提示这些细胞因子在疾病中可能具有病理生理作用。在本研究中,我们使用在标准化培养系统中检测的高度纯化祖细胞群体,测试了TNF-α和IFN-γ对造血发育表型和功能定义阶段的作用。我们假设IFN-γ和TNF-α的抑制作用可能与程序性细胞死亡的诱导有关。在甲基纤维素集落试验中,IFN-γ和TNF-α抑制早期造血细胞的生长,包括定向CD34+CD38+祖细胞和表型上不太成熟的CD34+CD38-细胞,在750-1000 U/ml的IFN-γ和10-15 ng/ml的TNF-α范围内,集落形成减少50%。在补充两种细胞因子组合的培养物中观察到比单独用IFN-γ或TNF-α处理的培养物更强的抑制作用。当以这些浓度使用时,IFN-γ和TNF-α分别抑制富含CD34(+)的长期培养起始细胞生长88%和68%。IFN-γ和TNF-α触发全骨髓和CD34+细胞的凋亡,这可通过低分子量DNA提取后特征性DNA降解模式的存在以及通过原位末端脱氧核苷酸转移酶测定检测凋亡细胞来识别。我们推测,体内造血组织长期暴露于TNF-α和IFN-γ可能导致干细胞和祖细胞池的广泛耗竭。这些细胞因凋亡而非增殖的短暂抑制而死亡可能是导致长期血液学后果的原因。